secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lineage Cell Therapeutics, Inc. (LCTX)
CIK:        0000876343
Form:       8-K
Filed at:   2022-06-17T23:59:59+00:00
Accession:  0001493152-22-017162
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lineage Cell Therapeutics holds annual meeting; all director nominees elected, auditor ratified, say-on-pay approved
--------------------------------------------------------------------------------

- Elected nine directors: Kingsley, Amin, Andrews, Bailey, Bradsher, Culley, Jayasuriya, Mulroy, Russell.
- Ratified WithumSmith+Brown as auditor: 114.8M for, 0.5M against, 1.4M abstain.
- Advisory say-on-pay approved: 70.9M for, 1.8M against, 1.8M abstain.
- Broker non-votes of 42.2M on director elections and say-on-pay.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/876343/000149315222017162/0001493152-22-017162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/876343/000149315222017162/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-017162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer